Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
Sponsor and Collaborators
Wyeth
Contact
Trial Manager
clintrialparticipation@wyeth.com
50 Study Locations
Principal Investigator
Study Director: Medical Monitor
Wyeth
Clinical Trials.gov Identifier
NCT00631371
Continue Reading